HomeCompareADNPX vs KMB

ADNPX vs KMB: Dividend Comparison 2026

ADNPX yields 11.73% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KMB wins by $2.5K in total portfolio value· pulled ahead in Year 10
10 years
ADNPX
ADNPX
● Live price
11.73%
Share price
$17.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.4K
Annual income
$2,440.68
Full ADNPX calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.47
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,211.33
Full KMB calculator →

Portfolio growth — ADNPX vs KMB

📍 KMB pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADNPXKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADNPX + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADNPX pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADNPX
Annual income on $10K today (after 15% tax)
$997.07/yr
After 10yr DRIP, annual income (after tax)
$2,074.58/yr
KMB
Annual income on $10K today (after 15% tax)
$445.84/yr
After 10yr DRIP, annual income (after tax)
$4,429.63/yr
At 15% tax rate, KMB beats the other by $2,355.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADNPX + KMB for your $10,000?

ADNPX: 50%KMB: 50%
100% KMB50/50100% ADNPX
Portfolio after 10yr
$44.6K
Annual income
$3,826.00/yr
Blended yield
8.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

ADNPX
No analyst data
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.5% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADNPX buys
0
KMB buys
0
No recent congressional trades found for ADNPX or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADNPXKMB
Forward yield11.73%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$43.4K$45.9K
Annual income after 10y$2,440.68$5,211.33
Total dividends collected$17.9K$21.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: ADNPX vs KMB ($10,000, DRIP)

YearADNPX PortfolioADNPX Income/yrKMB PortfolioKMB Income/yrGap
1$11,873$1,173.02$11,314$613.68+$559.00ADNPX
2$14,006$1,301.62$12,865$759.19+$1.1KADNPX
3$16,421$1,434.98$14,709$943.96+$1.7KADNPX
4$19,143$1,572.38$16,919$1,180.17+$2.2KADNPX
5$22,196$1,713.09$19,588$1,484.33+$2.6KADNPX
6$25,606$1,856.36$22,838$1,879.06+$2.8KADNPX
7$29,400$2,001.46$26,832$2,395.60+$2.6KADNPX
8$33,606$2,147.67$31,788$3,077.63+$1.8KADNPX
9$38,252$2,294.29$38,000$3,986.82+$252.00ADNPX
10← crossover$43,371$2,440.68$45,872$5,211.33$2.5KKMB

ADNPX vs KMB: Complete Analysis 2026

ADNPXStock

Under normal circumstances, substantially all of the fund's assets are invested in a portfolio of equity securities including common stocks and other equity investments or ownership interests in business enterprises that are relevant to the fund's investment theme of transformational innovation. The fund's investments in foreign equity securities are in both developed and emerging markets. It invests in American Depositary Receipts (''ADRs'') and securities sold on foreign exchanges and securities denominated in foreign currencies when purchasing foreign equities. The fund is non-diversified.

Full ADNPX Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this ADNPX vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADNPX vs SCHDADNPX vs JEPIADNPX vs OADNPX vs KOADNPX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.